CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Material agreement · Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Item 12 · Item 7
- 8-K Event Item 5 · Item 7
- 10-Q Report Quarterly Report
- 8-K Event Item 12 · Item 7
- 10-K Report Annual Report
- 8-K Event Item 12 · Item 7
- 10-Q Report Quarterly Report
- 8-K Event Item 12 · Item 7
- 10-Q Report Quarterly Report
- 8-K Event Item 5 · Item 7
- 8-K Event Item 7 · Item 9
Page 18 of 21 · 404 filings